# Panitumumab vs Bevacizumab Added to Standard First-line Chemotherapy and Overall Survival Among Patients With <i>RAS</i> Wild-type, Left-Sided Metastatic Colorectal Cancer

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/panitumumab-vs-bevacizumab-added-to-standard-first-line-chemotherapy-and-overall/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Jun Watanabe,Kei Muro,Kohei Shitara,Kentaro Yamazaki,Manabu Shiozawa,Hisatsugu Ohori,Atsuo Takashima,Mitsuru Yokota,Akitaka Makiyama,Naoya Akazawa,Hitoshi Ojima,Yasuhiro Yuasa,Keisuke Miwa,Hirofumi Yasui,Eiji Oki,Takeo Sato,Takeshi Naitoh,Yoshito Komatsu,Takeshi Kato,Masamitsu Hihara,Junpei Soeda,Toshihiro Misumi,Kouji Yamamoto,Kiwamu Akagi,Atsushi Ochiai,Hiroyuki Uetake,Katsuya Tsuchihara,Takayuki Yoshino |
| Citations | 265 |
| DOI | 10.1001/jama.2023.4428 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://jamanetwork.com/journals/jama/articlepdf/2803803/jama_watanabe_2023_oi_230036_1681230425.45792.pdf |
| OpenAlex ID | https://openalex.org/W4366236521 |
| PMID | 37071094 |
| Type | article |
| Year | 2023 |

## Paper authors

- [Takeshi Kato](https://scholariq.org/researchers/takeshi-kato/)

## Paper journal

- [JAMA](https://scholariq.org/journals/jama/)

## Paper primary topic

- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)

## Paper topics

- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)
- [Colorectal Cancer Surgical Treatments](https://scholariq.org/topics/colorectal-cancer-surgical-treatments/)
- [Cancer Research and Treatments](https://scholariq.org/topics/cancer-research-and-treatments/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.